trial · primary record
ST-920
Fabry Disease
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2025-04-10 |
| Primary endpoint | Incidence of Treatment-emergent Adverse Events (TEAEs) - All |
| Registry ID | NCT04046224 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:47.328Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04046224
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.